12:00 AM
Sep 17, 2012
 |  BC Week In Review  |  Financial News  |  Other Financial News

Helix BioMedix financial update

Helix BioMedix said its board approved a 1-for-300 reverse stock split. Prior to the split, the company has 49.7 million shares outstanding. All stockholders owning...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >